Insider trading

Period: 120 months Stock: TECH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

123 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

123 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

123 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

123 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
123 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
123 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

123 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Jan 2021
Hippel James Chief Financial Officer
Sold, plan not stated 6×
$3.34M 10,000 at 333.63
52.3%
Sold half or more
7 Dec 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$1.54M 5,000 at 308.00
2.9%
30 Nov 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 3×
$3.28M 10,857 at 301.94
63.9%
Sold half or more
18 Nov 2020
Sold, plan not stated
$1.52M 5,000 at 303.34
34.2%
11 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 2×
$2.27M 7,391 at 307.05
44.7%
9 Nov 2020
Seth Alpna Director
Sold, plan not stated 2×
$1.54M 5,023 at 306.62
70.1%
Sold half or more
9 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 5×
$1.12M 3,600 at 309.79
28.3%
6 Nov 2020
STEER RANDOLPH C Director
Sold, plan not stated 6×
$3.02M 10,000 at 301.99
66.2%
Sold half or more
6 Nov 2020
HIGGINS JOHN L Director
Sold, plan not stated 3×
$1.50M 5,000 at 300.35
53.1%
Sold half or more
5 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 10×
$2.52M 8,809 at 286.12
49.1%
4 Nov 2020
Hippel James Chief Financial Officer
Sold, plan not stated 4×
$1.95M 7,100 at 274.00
43.7%
9 Jul 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 8×
$2.50M 9,079 at 275.76
67.8%
Sold half or more
7 Jul 2020
Hippel James Chief Financial Officer
Sold, plan not stated 3×
$699.48K 2,577 at 271.43
21.7%
6 Jul 2020
Hippel James Chief Financial Officer
Sold, plan not stated 5×
$5.84M 21,502 at 271.61
69.8%
Sold half or more
29 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 4×
$2.07M 7,909 at 262.00
100%
Sold half or more
29 May 2020
WIENS HAROLD J Director
Sold, plan not stated
$1.04M 3,985 at 260.00
45.1%
28 May 2020
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 2×
$1.56M 5,995 at 260.14
58.2%
Sold half or more
28 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated
$897.13K 3,448 at 260.19
100%
Sold half or more
22 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 2×
$3.38M 12,600 at 267.93
100%
Sold half or more
21 May 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated 2×
$2.95M 11,037 at 267.49
100%
Sold half or more
21 May 2020
Sold, plan not stated 4×
$1.33M 5,000 at 266.42
35.2%
6 May 2020
WIENS HAROLD J Director
Sold, plan not stated
$1.07M 4,260 at 250.00
44.9%
30 Apr 2020
WIENS HAROLD J Director
Sold, plan not stated
$900.00K 4,000 at 225.00
43.4%
4 Mar 2020
Eansor Norman David President-Protein Sciences
Sold, plan not stated
$275.57K 1,387 at 198.68
100%
Sold half or more
12 Feb 2020
HIGGINS JOHN L Director
Sold, plan not stated
$1.03M 5,000 at 205.23
55.4%
Sold half or more
6 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$2.23M 10,276 at 217.28
7.3%
3 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$1.74M 7,999 at 217.56
5.8%
2 Jan 2020
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 5×
$4.34M 19,843 at 218.59
13.2%
24 Dec 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$104.65K 471 at 222.18
0.4%
23 Dec 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$146.35K 659 at 222.08
0.5%
20 Dec 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 2×
$2.56M 11,534 at 222.06
8.1%
12 Dec 2019
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated 4×
$1.72M 8,000 at 215.60
74.7%
Sold half or more
10 Dec 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$156.07K 703 at 222.01
0.5%
4 Dec 2019
WIENS HAROLD J Director
Sold, plan not stated 4×
$435.69K 2,000 at 217.85
27.7%
29 Nov 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$22.26K 100 at 222.62
0.1%
27 Nov 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$2.61M 11,772 at 222.12
8.0%
25 Nov 2019
Nusse Roeland Director
Sold, plan not stated
$1.83M 8,347 at 219.33
40.3%
22 Nov 2019
Hippel James Chief Financial Officer
Sold, plan not stated 2×
$5.10M 23,651 at 215.59
71.8%
Sold half or more
21 Nov 2019
Hippel James Chief Financial Officer
Sold, plan not stated
$2.44M 11,349 at 215.36
54.9%
Sold half or more
9 Sep 2019
Kummeth Charles R. Chief Executive Officer · indirect
Bought 2×
$37.00K 200 at 185.00
opened
First buy on file
7 Aug 2019
Bought
$95.53K 500 at 191.06
6.1%
First buy on file
10 Jul 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated 3×
$3.62M 16,969 at 213.12
15.5%
9 Jul 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$3.19M 15,037 at 212.43
14.0%
8 Jul 2019
Kummeth Charles R. Chief Executive Officer
Sold, plan not stated
$3.83M 17,994 at 212.75
16.3%
12 Jun 2019
Eansor Norman David SVP - Novus Biologicals
Sold, plan not stated
$670.16K 3,117 at 215.00
100%
Sold half or more
4 Jun 2019
HIGGINS JOHN L Director
Sold, plan not stated
$1.02M 5,000 at 203.67
58.6%
Sold half or more
24 May 2019
Furlow Brenda S. SVP - General Counsel
Sold, plan not stated
$1.08M 5,400 at 200.00
71.2%
Sold half or more
1 May 2019
Hippel James Chief Financial Officer
Sold, plan not stated
$7.11M 35,000 at 203.08
88.9%
Sold half or more
24 Aug 2018
Sold, plan not stated
$942.33K 5,000 at 188.47
39.3%
23 Aug 2018
HIGGINS JOHN L Director
Sold, plan not stated
$1.88M 10,000 at 187.92
76.9%
Sold half or more
Showing 51–100 of 123. ← Newer Page 2 of 3 Older →